Endodermal Sinus Tumor: Clinical Trials

49 trials for Endodermal Sinus Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

35 completed, 6 recruiting, 4 active not recruiting, 2 unknown. 20 Phase 2, 14 Phase 3, 12 Phase 1, 4 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 220Completed 16, Unknown 2, Active not recruiting 1, Recruiting 1
Phase 314Completed 10, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 112Completed 5, Recruiting 3, Active not recruiting 2, Not yet recruiting 1, Unknown 1
Not applicable4Completed 4

Follow Endodermal Sinus Tumor: new trials by email Literature Review of Endodermal Sinus Tumor trials Research Report on Endodermal Sinus Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
SC-CAR.GPC3xIL15.21 CAR T cells - Solid Tumor (Excluding CNS), Hepatocellular Carcinoma
Phase 1Not yet recruitingSeattle Children's Hospital212026-04-012025-11-04
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
SC-CAR.GPC3xIL15.21 CAR T cells - Solid Tumor (Excluding CNS), Liver Cell Carcinoma
Phase 1RecruitingSeattle Children's Hospital212025-12-222026-02-17
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
21.15.GPC3-CAR T cells - Hepatoblastoma, Hepatocellular Carcinoma
Phase 1RecruitingBaylor College of Medicine212025-06-102025-11-03
Agnostic Therapy in Rare Solid Tumors
Nivolumab - Urachal Cancer, Parathyroid Carcinoma
Phase 2Active not recruitingInstituto do Cancer do Estado de São Paulo282024-07-162026-10-13
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
CARE T cells - Liver Cancer, Rhabdomyosarcoma
Phase 1RecruitingBaylor College of Medicine242024-05-242026-08-06
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
High-dose chemotherapy (TI- 2 cycles, CE- 3 cycles ) - Germ Cell Tumor
Phase 2RecruitingN.N. Petrov National Medical Research Center of Oncology252024-03-012025-08-03
Molecular Epidemiology of Pediatric Germ Cell Tumors
Questionnaire Administration, Tumor Specimen Collection, Germline DNA Samples - Germ Cell Tumor, Germinoma
RecruitingChildren's Oncology Group11512023-04-122025-10-24
Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor
Thalidomide combined with TGA chemotherapy (nab-paclitaxel + gemcitabine+ epirubicin) - Germ Cell Tumor, Yolk Sac Tumor
Phase 2CompletedShandong First Medical University202021-11-112025-09-18
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
AGAR T cells - Liver Cancer, Rhabdomyosarcoma
Phase 1Active not recruitingBaylor College of Medicine142021-08-082026-01-21
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors
CATCH T cells - Liver Cell Carcinoma, Solid Tumor
Phase 1Active not recruitingBaylor College of Medicine122021-06-172026-03-06
Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children
sirolimus combined with chemotherapy in the treatment of recurrent/refractory yolk sac tumor in children - Germ Cell Tumor, Yolk Sac Tumor
Phase 2 / Phase 3CompletedShandong First Medical University322020-06-012025-09-19
Role of Axumin PET Scan in Germ Cell Tumor
Axumin PET scan - Testis Cancer, Germ Cell Tumor
CompletedUniversity of Texas Southwestern Medical Center102018-03-012025-08-11
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Best Practice, Biopsy Procedure, Biospecimen Collection - Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma
Phase 3RecruitingChildren's Oncology Group17802017-05-252026-08-25
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
paclitaxel, ifosfamide, cisplatin - Germ Cell Tumor, Teratoma
Phase 3Active not recruitingAlliance for Clinical Trials in Oncology4202015-08-062026-06-16
DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings
Laboratory Biomarker Analysis, Questionnaire Administration - Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor
CompletedChildren's Oncology Group9322011-11-012019-01-07
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
Carboplatin, Filgrastim, Ifosfamide - Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Malignant Germ Cell Tumor
Phase 2CompletedChildren's Oncology Group202007-11-052018-08-29
Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment
sunitinib malate - Extragonadal Germ Cell Tumor, Ovarian Cancer
Phase 2CompletedMemorial Sloan Kettering Cancer Center102007-03-012015-10-27
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
pegfilgrastim, cisplatin, ifosfamide - Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor
Phase 2CompletedMemorial Sloan Kettering Cancer Center602007-03-012017-11-28
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
carboplatin, etoposide, ifosfamide - Childhood Germ Cell Tumor, Ovarian Cancer
Phase 2CompletedMasonic Cancer Center, University of Minnesota232006-12-192022-05-17
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
filgrastim, lenograstim, pegfilgrastim - Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor
Phase 1 / Phase 2UnknownUniversity of Southampton232006-11-012013-01-23

Showing 20 of 49. Sign in to see all of them.

Narrower conditions

Teratoma (35)  ·  Testicular Neoplasms (35)  ·  Carcinoma, Embryonal (32)  ·  Seminoma (29)  ·  Testicular Germ Cell Tumor (23)  ·  Teratoma, Testicular (20)  ·  Carcinoma, Ovarian Epithelial (16)  ·  Wilms Tumor (16)  ·  Breast Neoplasms (15)  ·  Neuroblastoma (15)  ·  Burkitt Lymphoma (14)  ·  Hodgkin Disease (14)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (14)  ·  Lymphoma, Follicular (14)

Broader conditions

Mesonephroma (49)  ·  Neoplasms by Histologic Type (49)  ·  Urogenital Diseases (44)  ·  Neoplasms by Site (42)  ·  Neoplasms, Germ Cell and Embryonal (42)  ·  Male Urogenital Diseases (41)  ·  Urogenital Neoplasms (41)  ·  Neoplasms (40)  ·  Endocrine Gland Neoplasms (36)  ·  Endocrine System Diseases (36)  ·  Genital Diseases (36)  ·  Genital Diseases, Male (36)  ·  Genital Neoplasms, Male (36)  ·  Gonadal Disorders (36)  ·  Testicular Diseases (35)

Interventions

Cisplatin (13)  ·  Etoposide (10)  ·  Ifosfamide (10)  ·  Paclitaxel (10)  ·  Bleomycin (8)  ·  Filgrastim (8)  ·  Carboplatin (7)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Peripheral Blood Stem Cell Transplantation (3)  ·  pegfilgrastim (3)  ·  Cyclophosphamide (2)  ·  Drug Therapy (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Radiotherapy (2)  ·  Therapeutics (2)

Sponsors

Fred Hutchinson Cancer Center (7)  ·  Children's Oncology Group (5)  ·  Memorial Sloan Kettering Cancer Center (5)  ·  Baylor College of Medicine (4)  ·  European Organisation for Research and Treatment of Cancer - EORTC (4)  ·  Alliance for Clinical Trials in Oncology (2)  ·  Medical Research Council (2)  ·  National Cancer Institute (NCI) (2)  ·  Seattle Children's Hospital (2)  ·  Shandong First Medical University (2)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Cancer Treatment Centers of America (1)  ·  City of Hope Medical Center (1)  ·  Duke University (1)  ·  Eastern Cooperative Oncology Group (1)

Countries

United States (36)  ·  United Kingdom (10)  ·  Australia (5)  ·  Belgium (5)  ·  France (5)  ·  Germany (5)  ·  Netherlands (5)  ·  Canada (4)  ·  Denmark (4)  ·  Italy (4)  ·  Puerto Rico (4)  ·  Slovakia (4)  ·  Spain (4)  ·  Switzerland (4)  ·  Austria (3)

Top investigators

Robert J. Motzer, MD (4)  ·  David Steffin, MD (3)  ·  Darren Feldman, MD (2)  ·  Jingfu Wang, MD (2)  ·  Robert A. Huddart, MD (2)  ·  A. L Frazier (1)  ·  Aleksei M Belyaev, MD,DSc,Prof. (1)  ·  Anastasios Raptis, MD (1)  ·  Anne Frazier, MD (1)  ·  Camila MV Moniz, Doctor (1)  ·  Carlos Rodriguez-Galindo (1)  ·  Claude Sportes, MD (1)  ·  Colleen Annesley (1)  ·  Colleen Annesley, MD (1)  ·  Corinne Summers (1)

Results publications

PMID 15459300, PMID 15999102, PMID 17235042, PMID 17634488, PMID 18974373, PMID 19547919, PMID 21059637, PMID 25001888, PMID 25456363, PMID 30563754, PMID 31355926, PMID 37783480, PMID 39028926, PMID 39167741

NIH funding

U10CA098543 (2), 2005 (1), P30CA008748 (1), P30CA033572 (1), R01CA093891 (1), U10CA021115 (1), U10CA031946 (1), U10CA180821 (1), U10CA180886 (1)